Skip to main content
IRS-authorized e-file provider · not the IRS

Nonprofit · EIN 13-3633501

MUCOLIPIDOSIS TYPE IV FOUNDATION INC

Also known as ATTN RANDY GOLD

Tax-exempt (reinstated) · ATLANTA, GA 30329

Financials

$1.1M$656K2023$3.8M$3.1M2024
Revenue Expenses · by fiscal year end
Financials of MUCOLIPIDOSIS TYPE IV FOUNDATION INC by year, from its e-filed returns
Year endedFormRevenueExpensesNet incomeTotal assetsLiabilitiesNet assets
December 31, 2024990$3,776,356$3,084,160$692,196$2,166,558$3,334$2,163,224
December 31, 2023990$1,080,997$656,195$424,802$1,477,459$6,431$1,471,028
Financial details: 990 for the year ended December 31, 2024

Revenue

Contributions, gifts and grants
$3,760,853
Program service revenue
$0
Investment income
$0
Other revenue
$15,503

Expenses

Grants and similar amounts paid
$2,666,142
Compensation of officers, directors and key employees
$208,000
Other salaries and wages
$7,967
Salaries, compensation and benefits (total)
$245,710
Professional fundraising fees
$0
Accounting fees
$2,442
Occupancy
$4,200
Travel
$26,442
Program services (functional)
$3,059,306
Management and general (functional)
$24,854

Balance sheet and other

Total assets, start of year
$1,477,459
Total assets, end of year
$2,166,558
Total liabilities, end of year
$3,334
Net assets, end of year
$2,163,224
Gross receipts
$3,776,356
Employees
2
Volunteers
6
Year formed
1982
State of legal domicile
GA

From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.

Officers, directors and key employees

As listed on the 990 for the year ended December 31, 2024, highest compensation first.

NameTitleHours / weekCompensation
REBECCA OBERMANEXECUTIVE DIRECTOR
Key employee, Highest-paid employee
40$213,815
RANDY GOLDPRESIDENT TREASURER
Trustee or director, Officer
5$0
CAROLINE GOLDSECRETARY
Trustee or director, Officer
2$0
PAULA KUTNERBOARD MEMBER
Trustee or director
2$0
MICHAEL FRIEDMANBOARD MEMBER
Trustee or director
2$0
DEBRA GOLDSCHMIDTBOARD MEMBER
Trustee or director
2$0
NATHANIEL FERNHOFFBOARD MEMBER
Trustee or director
2$0
990 for the year ended December 31, 2023: 7 people
NameTitleHours / weekCompensation
REBECCA OBERMANEXECUTIVE DIRECTOR
Key employee, Highest-paid employee
40$197,833
RANDY GOLDPRESIDENT TREASURER
Trustee or director, Officer
5$0
CAROLINE GOLDSECRETARY
Trustee or director, Officer
2$0
PAULA KUTNERBOARD MEMBER
Trustee or director
2$0
MICHAEL FRIEDMANBOARD MEMBER
Trustee or director
2$0
DEBRA GOLDSCHMIDTBOARD MEMBER
Trustee or director
2$0
NATHANIEL FERNHOFFBOARD MEMBER
Trustee or director
2$0

Address and contacts

Address (IRS master file)
1668 ADELIA PL NE, ATLANTA, GA 30329-3808
In care of
% RANDY GOLD
Principal officer (990 for 2024)
Randy Gold, 1668 Adelia Place, Atlanta, GA 30329
Signed the 990
Randy Gold, President
Phone
(877) 654-5459

Mission

THE MUCOLIPIDOSIS TYPE IV FOUNDATION OPERATES TO RAISE CONTRIBUTIONS FROM INDIVIDUALS AND COMPANIES IN ORDER TO FUND MEDICAL RESEARCH GRANTS. ALL MEDICAL RESERACH GRANTS ARE PROVIDED TO RESEARCHERS STUDYING THE CAUSE AND SYMPTOMS OF MUCOLIPIDOSIS TYPE IV WITH THE HOPE OF FINDING A CURE FOR THIS DISEASE.

990 for the year ended December 31, 2024

Program accomplishments

  • RESEARCH TO CURE MUCOLIPIDOSIS TYPE IV - MASS GENERAL HOSPITAL
    Expenses $717,237 · grants $717,237
  • RESEARCH TO CURE MUCOLIPIDOSIS TYPE IV - UMASS CHAN MEDICAL SCHOOL
    Expenses $1,948,905 · grants $1,948,905
  • RESEARCH TO CURE MUCOLIPIDOSIS TYPE IV
    Expenses $393,164 · grants $393,164

What it must file and when

IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.

Tax yearYear endedDueIRS public records
2025December 31, 2025May 15, 2026Not on file
2024December 31, 2024May 15, 2025990 on file
2023December 31, 2023May 15, 2024990 on file

IRS record

EIN
13-3633501
Tax-exempt status
501(c)(3): Charitable, religious, educational or scientific organization
Foundation status
Publicly supported organization (170(b)(1)(A)(vi))
Donations deductible (Pub 78)
Public charity, 50% deduction limit
Exempt since
2012
Accounting year ends
December
Files
Form 990 or 990-EZ
Assets (IRS master file)
$2,166,558
Income (IRS master file)
$3,776,356

Revocation and reinstatement

Exemption revoked
February 15, 2011
Posted by the IRS
October 7, 2011
Reinstated
Effective February 15, 2011

From the IRS automatic revocation list: organizations that did not file a required return or e-Postcard for three consecutive years.

Filing history

FormYear endedRevenueExpensesAssetsReturn
990December 2024$3,776,356$3,084,160$2,166,558XML
990December 2023$1,080,997$656,195$1,477,459XML
990December 2022$860,271$653,162$1,047,509IRS
990December 2021–––IRS
990December 2020–––IRS

990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 13-3633501).

Questions about MUCOLIPIDOSIS TYPE IV FOUNDATION INC

What is the EIN of MUCOLIPIDOSIS TYPE IV FOUNDATION INC?
The employer identification number (EIN) of MUCOLIPIDOSIS TYPE IV FOUNDATION INC is 13-3633501.
Is MUCOLIPIDOSIS TYPE IV FOUNDATION INC tax-exempt?
Yes. The IRS revoked its exemption on February 15, 2011 and reinstated it effective February 15, 2011.
Are donations to MUCOLIPIDOSIS TYPE IV FOUNDATION INC tax-deductible?
Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
Which annual return does MUCOLIPIDOSIS TYPE IV FOUNDATION INC file?
Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
When is the next return of MUCOLIPIDOSIS TYPE IV FOUNDATION INC due?
The return for tax year 2025 (the year ending December 31, 2025) is due May 15, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
When did MUCOLIPIDOSIS TYPE IV FOUNDATION INC last file with the IRS?
The latest return in the IRS public files is the 990 for the year ended December 2024.
Who is the principal officer of MUCOLIPIDOSIS TYPE IV FOUNDATION INC?
The 990 for the year ended December 31, 2024 names Randy Gold.
Who are the officers and directors of MUCOLIPIDOSIS TYPE IV FOUNDATION INC?
The 990 for the year ended December 31, 2024 lists 7 people; 1 received compensation from the organization, the highest $213,815 (REBECCA OBERMAN, EXECUTIVE DIRECTOR).
How much revenue does MUCOLIPIDOSIS TYPE IV FOUNDATION INC have?
On its 990 for the year ended December 31, 2024 it reported revenue of $3,776,356, expenses of $3,084,160 and total assets of $2,166,558 at year end.

Other nonprofits in ATLANTA

All nonprofits in ATLANTA · Georgia · Voluntary health associations and medical disciplines